ID
25467
Description
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Keywords
Versions (2)
- 8/24/17 8/24/17 -
- 9/4/17 9/4/17 -
Uploaded on
September 4, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
study period ongoing concomitant medication starting dose of ropinirole Parkinson's Disease 101468/166
study period ongoing concomitant medication starting dose of ropinirole Parkinson's Disease 101468/166
Description
CONCOMITANT MEDICATIONS
Alias
- UMLS CUI-1
- C2347852
Description
Record .fill concomitant medication(s) (other than study drug) taken by the patient since taking the first dose of study drug through Day 14.
Data type
integer
Alias
- UMLS CUI [1]
- C2347852
Description
CONCOMITANT MEDICATIONS
Alias
- UMLS CUI-1
- C2347852
Description
Use generic name.
Data type
text
Alias
- UMLS CUI [1]
- C2347852
Description
start date of concomitant medication
Data type
date
Alias
- UMLS CUI [1]
- C2826734
Description
stop date of concomitant medication
Data type
text
Alias
- UMLS CUI [1]
- C2826744
Description
If not "continued" above, record the date.
Data type
date
Alias
- UMLS CUI [1]
- C2826744
Description
total daily dose of concomitant medication
Data type
integer
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C2347852
Description
If "other", specify.
Data type
text
Alias
- UMLS CUI [1]
- C0013153
Description
indication for medication
Data type
text
Alias
- UMLS CUI [1]
- C2826696
Similar models
study period ongoing concomitant medication starting dose of ropinirole Parkinson's Disease 101468/166
C2347852 (UMLS CUI [1,2])